Recent Peer Reviewed Publications

• 1. Panozzo CA
  2. Walsh EE
  3. Yang Z
  4. Wilson E
  5. Goswami J
  6. Stoszek SK
  7. Loback A
  8. Ng T
  9. Francis BM
  10. Simorellis AK
  11. Huang W
  12. Li L
  13. Vislay-Wade R
  14. Zheng Z
  15. Anderson EJ
  16. August A
  17. Chen G
  18. Falsey AR
  Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults.; Infectious diseases and therapy. 2024 Nov 16.
• 1. Frutos AM
  2. Ahmad HM
  3. Ujamaa D
  4. O'Halloran AC
  5. Englund JA
  6. Klein EJ
  7. Zerr DM
  8. Crossland M
  9. Staten H
  10. Boom JA
  11. Sahni LC
  12. Halasa NB
  13. Stewart LS
  14. Hamdan O
  15. Stopczynski T
  16. Schaffner W
  17. Talbot HK
  18. Michaels MG
  19. Williams JV
  20. Sutton M
  21. Hendrick MA
  22. Staat MA
  23. Schlaudecker EP
  24. Tesini BL
  25. Felsen CB
  26. Weinberg GA
  27. Szilagyi PG
  28. Anderson BJ
  29. Rowlands JV
  30. Khalifa M
  31. Martinez M
  32. Selvarangan R
  33. Schuster JE
  34. Lynfield R
  35. McMahon M
  36. Kim S
  37. Nunez VT
  38. Ryan PA
  39. Monroe ML
  40. Wang YF
  41. Openo KP
  42. Meek J
  43. Yousey-Hindes K
  44. Alden NB
  45. Armistead I
  46. Rao S
  47. Chai SJ
  48. Kirley PD
  49. Toepfer AP
  50. Dawood FS
  51. Moline HL
  52. Uyeki TM
  53. Ellington S
  54. Garg S
  55. Bozio CH
  56. Olson SM
  Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024.; MMWR. Morbidity and mortality weekly report; Vol 73(45), pp. 1022-1029. 2024 Nov 14.
• 1. O'Halloran AC
  2. Millman AJ
  3. Holstein R
  4. Olsen SJ
  5. Cummings C
  6. Chai SJ
  7. Kirley PD
  8. Alden NB
  9. Yousey-Hindes K
  10. Meek J
  11. Openo KP
  12. Fawcett E
  13. Ryan PA
  14. Leegwater L
  15. Henderson J
  16. McMahon M
  17. Lynfield R
  18. Angeles KM
  19. Bleecker M
  20. McGuire S
  21. Spina NL
  22. Tesini BL
  23. Gaitan MA
  24. Lung K
  25. Shiltz E
  26. Thomas A
  27. Talbott HK
  28. Schaffner W
  29. Hill M
  30. Reed C
  31. Garg S
  The burden of all-cause mortality following influenza-associated hospitalizations, FluSurv-NET, 2010-2019.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Nov 04.
• 1. Havers FP
  2. Whitaker M
  3. Melgar M
  4. Pham H
  5. Chai SJ
  6. Austin E
  7. Meek J
  8. Openo KP
  9. Ryan PA
  10. Brown C
  11. Como-Sabetti K
  12. Sosin DM
  13. Barney G
  14. Tesini BL
  15. Sutton M
  16. Talbot HK
  17. Chatelain R
  18. Daily Kirley P
  19. Armistead I
  20. Yousey-Hindes K
  21. Monroe ML
  22. Tellez Nunez V
  23. Lynfield R
  24. Esquibel CL
  25. Engesser K
  26. Popham K
  27. Novak A
  28. Schaffner W
  29. Markus TM
  30. Swain A
  31. Patton ME
  32. Kim L
  Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023.; JAMA network open; Vol 7(11), pp. e2444756. 2024 Nov 04.
• 1. Taylor CA
  2. Whitaker M
  3. Patton ME
  4. Melgar M
  5. Kirley PD
  6. Kawasaki B
  7. Yousey-Hindes K
  8. Openo KP
  9. Ryan PA
  10. Kim S
  11. Como-Sabetti K
  12. Solhtalab D
  13. Barney G
  14. Tesini BL
  15. Moran NE
  16. Sutton M
  17. Talbot HK
  18. Olsen K
  19. Havers FP
  Trends in COVID-19-Attributable Hospitalizations Among Adults With Laboratory-Confirmed SARS-CoV-2-COVID-NET, June 2020 to September 2023.; Influenza and other respiratory viruses; Vol 18(11), pp. e70021. 2024 Nov.
• 1. Saiman L
  2. Walsh EE
  3. Branche AR
  4. Barrett A
  5. Alba L
  6. Gollerkeri S
  7. Schillinger JA
  8. Phillips M
  9. Finelli L
  Impact of Age and Comorbid Conditions on Incidence Rates of COVID-19-Associated Hospitalizations, 2020-2021.; Influenza and other respiratory viruses; Vol 18(11), pp. e70016. 2024 Nov.
• 1. Naquin A
  2. O'Halloran A
  3. Ujamaa D
  4. Sundaresan D
  5. Masalovich S
  6. Cummings CN
  7. Noah K
  8. Jain S
  9. Kirley PD
  10. Alden NB
  11. Austin E
  12. Meek J
  13. Yousey-Hindes K
  14. Openo K
  15. Witt L
  16. Monroe ML
  17. Henderson J
  18. Nunez VT
  19. Lynfield R
  20. McMahon M
  21. Shaw YP
  22. McCahon C
  23. Spina N
  24. Engesser K
  25. Tesini BL
  26. Gaitan MA
  27. Shiltz E
  28. Lung K
  29. Sutton M
  30. Hendrick MA
  31. Schaffner W
  32. Talbot HK
  33. George A
  34. Zahid H
  35. Reed C
  36. Garg S
  37. Bozio CH
  Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults - Influenza Hospitalization Surveillance Network, United States, 2010-2023.; Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002); Vol 73(6), pp. 1-18. 2024 Oct 31.
• 1. Branche AR
  Real-world effectiveness studies of the benefit of RSV vaccines.; Lancet (London, England); Vol 404(10462), pp. 1498-1500. 2024 Oct 19.
• 1. Dobrzynski D
  2. Branche AR
  3. Falsey AR
  Combination seasonal vaccines for influenza, RSV, SARS-CoV-2, and other pathogens.; The Journal of infectious diseases. 2024 Oct 15.
• 1. Devine O
  2. Pham H
  3. Gunnels B
  4. Reese HE
  5. Steele M
  6. Couture A
  7. Iuliano D
  8. Sachdev D
  9. Alden NB
  10. Meek J
  11. Witt L
  12. Ryan PA
  13. Reeg L
  14. Lynfield R
  15. Ropp SL
  16. Barney G
  17. Tesini BL
  18. Shiltz E
  19. Sutton M
  20. Talbot HK
  21. Reyes I
  22. Havers FP
  Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach.; Influenza and other respiratory viruses; Vol 18(10), pp. e70026. 2024 Oct.
• 1. Fong Y
  2. Dang L
  3. Zhang B
  4. Fintzi J
  5. Chen S
  6. Wang J
  7. Rouphael NG
  8. Branche AR
  9. Diemert DJ
  10. Falsey AR
  11. Losada C
  12. Baden LR
  13. Frey SE
  14. Whitaker JA
  15. Little SJ
  16. Kamidani S
  17. Walter EB
  18. Novak RM
  19. Rupp R
  20. Jackson LA
  21. Yu C
  22. Magaret CA
  23. Molitor C
  24. Borate B
  25. Babu TM
  26. Kottkamp AC
  27. Luetkemeyer AF
  28. Immergluck LC
  29. Presti RM
  30. Bäcker M
  31. Winokur PL
  32. Mahgoub SM
  33. Goepfert PA
  34. Fusco DN
  35. Atmar RL
  36. Posavad CM
  37. Mu J
  38. Makowski M
  39. Makhene MK
  40. Nayak SU
  41. Roberts PC
  42. Follmann D
  43. Gilbert PB
  Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Sep 26.
• 1. Falsey AR
  2. Branche AR
  3. Peasley M
  4. Cole M
  5. Petrone KK
  6. Obrecht S
  7. Steinmetz K
  8. Smith T
  9. Owen A
  10. Anderson CS
  11. Overby C
  12. Peterson DR
  13. Walsh EE
  Short-Term Immunogenicity of Licensed Subunit RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) Compared to Community-Dwelling Older Adults.; Journal of the American Medical Directors Association. 2024 Sep 21.
• 1. Henrich TJ
  2. Bosch RJ
  3. Godfrey C
  4. Mar H
  5. Nair A
  6. Keefer M
  7. Fichtenbaum C
  8. Moisi D
  9. Clagett B
  10. Buck AM
  11. Deitchman AN
  12. Aweeka F
  13. Li JZ
  14. Kuritzkes DR
  15. Lederman MM
  16. Hsue PY
  17. Deeks SG
  Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV.; Cell reports. Medicine. 2024 Sep 17.
• 1. Hahn WO
  2. Parks KR
  3. Shen M
  4. Ozorowski G
  5. Janes H
  6. Ballweber-Fleming L
  7. Woodward Davis AS
  8. Duplessis C
  9. Tomai M
  10. Dey AK
  11. Sagawa ZK
  12. De Rosa SC
  13. Seese A
  14. Kallur Siddaramaiah L
  15. Stamatatos L
  16. Lee WH
  17. Sewall LM
  18. Karlinsey D
  19. Turner HL
  20. Rubin V
  21. Furth S
  22. MacPhee K
  23. Duff M
  24. Corey L
  25. Keefer MC
  26. Edupuganti S
  27. Frank I
  28. Maenza J
  29. Baden LR
  30. Hyrien O
  31. Sanders RW
  32. Moore JP
  33. Ward AB
  34. Tomaras GD
  35. Montefiori DC
  36. Rouphael N
  37. McElrath MJ
  Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.; The Journal of experimental medicine; Vol 221(10). 2024 Sep 05.
• 1. Branche AR
  2. Falsey AR
  3. Finelli L
  4. Walsh EE
  Residency in Long-Term Care Facilities: An Important Risk Factor for RSV Hospitalization.; The Journal of infectious diseases. 2024 Aug 23.